Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Skin cancer

Basal cell carcinoma—pay your money, take your choice

Superficial basal cell carcinomas are a common challenge in clinical dermatology because they are frequent and surgical approaches tend to scar. A large randomized trial comparing three nonsurgical approaches has shown that all had similar clinical outcomes—so, you pay your money and take your choice.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Levell, N. J., Igali, L., Wright, K. A. & Greenberg, D. C. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin. Exp. Dermatol. 38, 367–369 (2013).

    Article  CAS  Google Scholar 

  2. Epstein, E. H. Basal cell carcinomas: attack of the hedgehog. Nat. Rev. Cancer 8, 743–754 (2008).

    Article  CAS  Google Scholar 

  3. Weiss, G. J. & Korn, R. L. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors. Cancer 118, 5310–5319 (2012).

    Article  CAS  Google Scholar 

  4. Arits, A. H. et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 14, 647–654 (2013).

    Article  CAS  Google Scholar 

  5. Lee, Y. & Baron, E. D. Photodynamic therapy: current evidence and applications in dermatology. Semin. Cutan. Med. Surg. 30, 199–209 (2011).

    Article  CAS  Google Scholar 

  6. Telfer, N. R. et al. Guidelines for the management of basal cell carcinoma. Br. J. Dermatol. 159, 35–48 (2008).

    Article  CAS  Google Scholar 

  7. Wolberink, E. A., Pasch, M. C., Zeiler, M., van Erp, P. E. & Gerritsen, M. J. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J. Eur. Acad. Dermatol. Venereol. http://dx.doi.org/10.1111/j.1468-3083.2012.04628.x.

  8. McKay, K. M. et al. Thickness of superficial basal cell carcinoma predicts imiquimod efficacy, a proposal for thickness-based definition of superficial basal cell carcinoma. Br. J. Dermatol. http://dx.doi.org/10.1111/bjd.12402.

  9. Witheiler, D. D. & Cockerell, C. J. Histologic features and sensitivity of diagnosis of clinically unsuspected cutaneous melanoma. Am. J. Dermatopathol. 13, 551–556 (1991).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Epstein, E. Basal cell carcinoma—pay your money, take your choice. Nat Rev Clin Oncol 10, 489–490 (2013). https://doi.org/10.1038/nrclinonc.2013.133

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2013.133

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing